Artificial intelligence in drug discovery / edited by Nathan Brown, Benevolent AI, UK

Introduction; The History of Artificial Intelligence and Chemistry; Chemical Topic Modelling – An Unsupervised Approach Originating from Text-mining to Organize Chemical Data; Deep Learning and Chemical Data; Concepts and Applications of Conformal Prediction in Computational Drug Discovery; Non-applicability Domain. The Benefits of Defining “I don’t know” in Artificial Intelligence; Predicting Protein-Ligand Binding-Affinities; Virtual Screening with Convolutional Neural Networks; Machine Learning in the Area of Molecular Dynamics Simulations; Compound Design Using Generative Neural Networks; Junction Tree Variational Autoencoder for Molecular Graph Generation; AI via Matched Molecular Pair Analysis; Molecular de novo Design Through Deep Generative Models; Active Learning for Drug Discovery and Automated Data Curation; Data-driven Prediction of Organic Reaction Outcomes; ChemOS: an Orchestration Software to Democratize Autonomous Discovery; Summary and Outlook.

Medienart:

E-Book

Erscheinungsjahr:

[2021]

© 2021

Erschienen:

Cambridge: Royal Society of Chemistry ; 2021

© 2021

Reihe:

Drug discovery series - 75

RSC drug discovery

Sprache:

Englisch

Beteiligte Personen:

Brown, Nathan [HerausgeberIn]

Links:

doi.org [lizenzpflichtig]
pubs.rsc.org [lizenzpflichtig]

ISBN:

978-1-78801-684-1

978-1-83916-054-7

BKL:

54.80 / Angewandte Informatik

58.28 / Pharmazeutische Technologie

Themen:

Artificial intelligence
Artificial intelligence ; Medical applications
Arzneimittelforschung
Drugs
Drugs ; Design ; Computer simulation
Künstliche Intelligenz

Umfang:

1 Online-Ressource (xvii, 405 Seiten) ; Illustrationen

doi:

10.1039/9781788016841

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

1738864022